# Fox Factory Holding Corp: financial statements, quarterly

FOXF · Nasdaq · CIK 1424929 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/foxf.md) · [Financials](/companies/foxf/financials.md) · [Filings](/companies/foxf/filings.md) · [Insiders](/companies/foxf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/foxf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [331](/filings/0001424929-24-000128.md) | [332 d](/filings/0001424929-26-000012.md) | [333](/filings/0001424929-25-000050.md) | [348](/filings/0001424929-25-000076.md) | [359](/filings/0001424929-25-000092.md) | [353 d](/filings/0001424929-26-000012.md) | [355](/filings/0001424929-26-000035.md) | [375](/filings/0001424929-26-000049.md) | [376](/filings/0001424929-25-000092.md) | [361 d](/filings/0001424929-26-000012.md) | [369](/filings/0001424929-26-000035.md) | [358](/filings/0001424929-26-000049.md) |
| Cost of revenue | $m | [224](/filings/0001424929-24-000128.md) | [240 d](/filings/0001424929-26-000012.md) | [230](/filings/0001424929-25-000050.md) | [238](/filings/0001424929-25-000076.md) | [252](/filings/0001424929-25-000092.md) | [251 d](/filings/0001424929-26-000012.md) | [245](/filings/0001424929-26-000035.md) | [258](/filings/0001424929-26-000049.md) | [262](/filings/0001424929-25-000092.md) | [259 d](/filings/0001424929-26-000012.md) | [262](/filings/0001424929-26-000035.md) | [248](/filings/0001424929-26-000049.md) |
| Gross profit | $m | [107](/filings/0001424929-24-000128.md) | [92.3 d](/filings/0001424929-26-000012.md) | [103](/filings/0001424929-25-000050.md) | [111](/filings/0001424929-25-000076.md) | [107](/filings/0001424929-25-000092.md) | [102 d](/filings/0001424929-26-000012.md) | [110](/filings/0001424929-26-000035.md) | [117](/filings/0001424929-26-000049.md) | [114](/filings/0001424929-25-000092.md) | [102 d](/filings/0001424929-26-000012.md) | [106](/filings/0001424929-26-000035.md) | [110](/filings/0001424929-26-000049.md) |
| Research and development | $m | [8.9](/filings/0001424929-24-000128.md) | [13.8 d](/filings/0001424929-26-000012.md) | [14.4](/filings/0001424929-25-000050.md) | [14.8](/filings/0001424929-25-000076.md) | [16.1](/filings/0001424929-25-000092.md) | [15.0 d](/filings/0001424929-26-000012.md) | [17.0](/filings/0001424929-26-000035.md) | [17.8](/filings/0001424929-26-000049.md) | [18.6](/filings/0001424929-25-000092.md) | [15.9 d](/filings/0001424929-26-000012.md) | [18.5](/filings/0001424929-26-000035.md) | [18.6](/filings/0001424929-26-000049.md) |
| Operating income | $m | [41.4](/filings/0001424929-24-000128.md) | [11.3 d](/filings/0001424929-26-000012.md) | [8.9](/filings/0001424929-25-000050.md) | [18.6](/filings/0001424929-25-000076.md) | [18.8](/filings/0001424929-25-000092.md) | [11.4 d](/filings/0001424929-26-000012.md) | [(251)](/filings/0001424929-26-000035.md) | [18.5](/filings/0001424929-26-000049.md) | [15.1](/filings/0001424929-25-000092.md) | [(306) d](/filings/0001424929-26-000012.md) | [6.0](/filings/0001424929-26-000035.md) | [17.5](/filings/0001424929-26-000049.md) |
| Interest expense | $m | [3.5](/filings/0001424929-24-000128.md) | [7.9 d](/filings/0001424929-26-000012.md) | [13.3](/filings/0001424929-25-000050.md) | [13.9](/filings/0001424929-25-000076.md) | [14.2](/filings/0001424929-25-000092.md) | [13.5 d](/filings/0001424929-26-000012.md) | [12.9](/filings/0001424929-26-000035.md) | [14.4](/filings/0001424929-26-000049.md) | [13.9](/filings/0001424929-25-000092.md) | [12.4 d](/filings/0001424929-26-000012.md) | [11.9](/filings/0001424929-26-000035.md) | [11.9](/filings/0001424929-26-000049.md) |
| Income tax | $m | [3.5](/filings/0001424929-24-000128.md) | [(3.1) d](/filings/0001424929-26-000012.md) | [(1.3)](/filings/0001424929-25-000050.md) | [(0.4)](/filings/0001424929-25-000076.md) | [0.3](/filings/0001424929-25-000092.md) | [(4.1) d](/filings/0001424929-26-000012.md) | [(3.6)](/filings/0001424929-26-000035.md) | [2.8](/filings/0001424929-26-000049.md) | [2.3](/filings/0001424929-25-000092.md) | [(33.0) d](/filings/0001424929-26-000012.md) | [(0.6)](/filings/0001424929-26-000035.md) | [2.3](/filings/0001424929-26-000049.md) |
| Net income | $m | [35.3](/filings/0001424929-24-000128.md) | [4.1 d](/filings/0001424929-26-000012.md) | [(3.5)](/filings/0001424929-25-000092.md) | [5.4](/filings/0001424929-25-000092.md) | [4.8](/filings/0001424929-25-000092.md) | [(0.1) d](/filings/0001424929-26-000012.md) | [(260)](/filings/0001424929-26-000049.md) | [2.7](/filings/0001424929-26-000049.md) | [(0.6)](/filings/0001424929-25-000092.md) | [(287) d](/filings/0001424929-26-000012.md) | [(15.0)](/filings/0001424929-26-000049.md) | [4.1](/filings/0001424929-26-000049.md) |
| Diluted EPS | $ per share | [0.83](/filings/0001424929-24-000128.md) | not reported | [(0.08)](/filings/0001424929-25-000050.md) | [0.13](/filings/0001424929-25-000076.md) | [0.11](/filings/0001424929-25-000092.md) | not reported | [(6.23)](/filings/0001424929-26-000035.md) | [0.07](/filings/0001424929-26-000049.md) | [(0.02)](/filings/0001424929-25-000092.md) | not reported | [(0.36)](/filings/0001424929-26-000035.md) | [0.10](/filings/0001424929-26-000049.md) |
| Basic EPS | $ per share | [0.83](/filings/0001424929-24-000128.md) | not reported | [(0.08)](/filings/0001424929-25-000050.md) | [0.13](/filings/0001424929-25-000076.md) | [0.11](/filings/0001424929-25-000092.md) | not reported | [(6.23)](/filings/0001424929-26-000035.md) | [0.07](/filings/0001424929-26-000049.md) | [(0.02)](/filings/0001424929-25-000092.md) | not reported | [(0.36)](/filings/0001424929-26-000035.md) | [0.10](/filings/0001424929-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [83.6](/filings/0001424929-25-000007.md) | not reported | not reported | not reported | [71.7](/filings/0001424929-26-000012.md) | not reported | not reported | not reported | [58.0](/filings/0001424929-26-000012.md) | not reported | not reported |
| Current assets | $m | [737](/filings/0001424929-23-000152.md) | [768](/filings/0001424929-25-000007.md) | [765](/filings/0001424929-24-000057.md) | [792](/filings/0001424929-24-000109.md) | [811](/filings/0001424929-24-000128.md) | [728](/filings/0001424929-26-000012.md) | [714](/filings/0001424929-25-000050.md) | [747](/filings/0001424929-25-000076.md) | [759](/filings/0001424929-25-000092.md) | [746](/filings/0001424929-26-000049.md) | [764](/filings/0001424929-26-000035.md) | [764](/filings/0001424929-26-000049.md) |
| Total assets | $m | [1,674](/filings/0001424929-23-000152.md) | [2,242](/filings/0001424929-25-000007.md) | [2,248](/filings/0001424929-24-000057.md) | [2,266](/filings/0001424929-24-000109.md) | [2,288](/filings/0001424929-24-000128.md) | [2,235](/filings/0001424929-26-000012.md) | [1,938](/filings/0001424929-25-000050.md) | [1,965](/filings/0001424929-25-000076.md) | [1,975](/filings/0001424929-25-000092.md) | [1,672](/filings/0001424929-26-000049.md) | [1,662](/filings/0001424929-26-000035.md) | [1,636](/filings/0001424929-26-000049.md) |
| Current liabilities | $m | [192](/filings/0001424929-23-000152.md) | [222](/filings/0001424929-25-000007.md) | [223](/filings/0001424929-24-000057.md) | [253](/filings/0001424929-24-000109.md) | [253](/filings/0001424929-24-000128.md) | [260](/filings/0001424929-26-000012.md) | [224](/filings/0001424929-25-000050.md) | [246](/filings/0001424929-25-000076.md) | [255](/filings/0001424929-25-000092.md) | [260](/filings/0001424929-26-000049.md) | [256](/filings/0001424929-26-000035.md) | [246](/filings/0001424929-26-000049.md) |
| Total liabilities | $m | [433](/filings/0001424929-23-000152.md) | [1,021](/filings/0001424929-25-000007.md) | [1,056](/filings/0001424929-24-000057.md) | [1,069](/filings/0001424929-24-000109.md) | [1,091](/filings/0001424929-24-000128.md) | [1,034](/filings/0001424929-26-000012.md) | [999](/filings/0001424929-25-000050.md) | [1,006](/filings/0001424929-25-000076.md) | [1,019](/filings/0001424929-25-000092.md) | [1,002](/filings/0001424929-26-000049.md) | [1,003](/filings/0001424929-26-000035.md) | [970](/filings/0001424929-26-000049.md) |
| Long-term debt | $m | not reported | [359](/filings/0001424929-25-000007.md) | [356](/filings/0001424929-24-000057.md) | [540](/filings/0001424929-24-000109.md) | [534](/filings/0001424929-24-000128.md) | [528](/filings/0001424929-26-000012.md) | [523](/filings/0001424929-25-000050.md) | [517](/filings/0001424929-25-000076.md) | [512](/filings/0001424929-25-000092.md) | [497](/filings/0001424929-26-000049.md) | [485](/filings/0001424929-26-000035.md) | [478](/filings/0001424929-26-000049.md) |
| Current portion of debt | $m | not reported | [14.3](/filings/0001424929-25-000007.md) | [14.3](/filings/0001424929-24-000057.md) | [24.3](/filings/0001424929-24-000109.md) | [24.3](/filings/0001424929-24-000128.md) | [24.3](/filings/0001424929-26-000012.md) | [24.3](/filings/0001424929-25-000050.md) | [24.3](/filings/0001424929-25-000076.md) | [24.3](/filings/0001424929-25-000092.md) | [26.9](/filings/0001424929-26-000049.md) | [26.9](/filings/0001424929-26-000035.md) | [26.9](/filings/0001424929-26-000049.md) |
| Shareholders' equity | $m | [1,241](/filings/0001424929-23-000152.md) | [1,222](/filings/0001424929-24-000128.md) | [1,192](/filings/0001424929-24-000057.md) | [1,196](/filings/0001424929-24-000109.md) | [1,197](/filings/0001424929-24-000128.md) | [1,201](/filings/0001424929-26-000049.md) | [940](/filings/0001424929-26-000049.md) | [959](/filings/0001424929-26-000049.md) | [956](/filings/0001424929-25-000092.md) | [670](/filings/0001424929-26-000049.md) | [659](/filings/0001424929-26-000049.md) | [667](/filings/0001424929-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [130 d](/filings/0001424929-24-000128.md) | [52.1 d](/filings/0001424929-26-000012.md) | [9.4](/filings/0001424929-25-000050.md) | [26.7 d](/filings/0001424929-25-000076.md) | [14.1 d](/filings/0001424929-25-000092.md) | [81.7 d](/filings/0001424929-26-000012.md) | [0.7](/filings/0001424929-26-000035.md) | [36.8 d](/filings/0001424929-26-000049.md) | [5.3 d](/filings/0001424929-25-000092.md) | [18.2 d](/filings/0001424929-26-000012.md) | [(16.1)](/filings/0001424929-26-000035.md) | [29.2 d](/filings/0001424929-26-000049.md) |
| Capital expenditure | $m | [8.8 d](/filings/0001424929-24-000128.md) | [14.8 d](/filings/0001424929-26-000012.md) | [9.9](/filings/0001424929-25-000050.md) | [11.3 d](/filings/0001424929-25-000076.md) | [10.9 d](/filings/0001424929-25-000092.md) | [12.0 d](/filings/0001424929-26-000012.md) | [7.2](/filings/0001424929-26-000035.md) | [12.5 d](/filings/0001424929-26-000049.md) | [7.5 d](/filings/0001424929-25-000092.md) | [6.8 d](/filings/0001424929-26-000012.md) | [5.4](/filings/0001424929-26-000035.md) | [4.1 d](/filings/0001424929-26-000049.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001424929-24-000128.md) | [25.0 d](/filings/0001424929-26-000012.md) | [25.0](/filings/0001424929-25-000050.md) | [0.0 d](/filings/0001424929-25-000076.md) | [0.0 d](/filings/0001424929-25-000092.md) | [0.0 d](/filings/0001424929-26-000012.md) | [0.0](/filings/0001424929-25-000050.md) | [0.0 d](/filings/0001424929-25-000076.md) | [0.0 d](/filings/0001424929-25-000092.md) | [0.0 d](/filings/0001424929-26-000012.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [42.4](/filings/0001424929-23-000152.md) | [42.5](/filings/0001424929-24-000057.md) | [42.5](/filings/0001424929-24-000109.md) | [42.5](/filings/0001424929-24-000128.md) | [41.7](/filings/0001424929-25-000050.md) | [41.7](/filings/0001424929-25-000076.md) | [41.7](/filings/0001424929-25-000092.md) | [41.7](/filings/0001424929-26-000035.md) | [41.9](/filings/0001424929-26-000049.md) | [41.8](/filings/0001424929-25-000092.md) | [41.9](/filings/0001424929-26-000035.md) | [42.3](/filings/0001424929-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,031,001 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001424929-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.